1. Home
  2. CYTK vs FLS Comparison

CYTK vs FLS Comparison

Compare CYTK & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.50

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Flowserve Corporation

FLS

Flowserve Corporation

HOLD

Current Price

$77.09

Market Cap

9.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
FLS
Founded
1997
1790
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.1B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
FLS
Price
$62.50
$77.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
10
Target Price
$82.38
$77.10
AVG Volume (30 Days)
2.2M
1.0M
Earning Date
02-26-2026
02-17-2026
Dividend Yield
N/A
1.09%
EPS Growth
N/A
69.42
EPS
N/A
3.44
Revenue
$87,211,000.00
$4,687,417,000.00
Revenue This Year
$339.72
$5.69
Revenue Next Year
$79.08
$3.92
P/E Ratio
N/A
$22.44
Revenue Growth
2609.26
3.19
52 Week Low
$29.31
$37.34
52 Week High
$70.98
$77.54

Technical Indicators

Market Signals
Indicator
CYTK
FLS
Relative Strength Index (RSI) 47.75 72.25
Support Level $60.30 $73.44
Resistance Level $65.08 $73.55
Average True Range (ATR) 2.91 1.40
MACD -0.01 0.44
Stochastic Oscillator 45.74 94.09

Price Performance

Historical Comparison
CYTK
FLS

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

Share on Social Networks: